Effectiveness of a Cognitive Behavioral Treatment for Reducing Atypical Antipsychotic Medication Health Risks in People With Serious Mental Illness
Sponsor study identifier
NIH
Secondary identifiers
NIH
interventional
333
0 countries
N/A
Study Start
July 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
July 2011
Actual (reported)Study Completion
July 2011
Actual (reported)This study will evaluate the effectiveness of a cognitive behavioral treatment in reducing significant medical risk factors often associated with people who have a serious mental illness and are taking atypical antipsychotic medications.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 2011
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 2006
Date type not reportedThis date has not been verified as actual or estimated.
June 30, 2008
Actual (reported)July 3, 2008
Actual (reported)July 2011
Actual (reported)July 2011
Actual (reported)Average weight loss; body mass index; and effects across other behavioral, clinical, physiological, and ancillary measures
Measured at Month 12
Ability of behavioral intervention to offset significant medical risk factors often associated with people living with mental illness
Measured at Month 12
Participants will receive cognitive behavioral sessions.
Participants will receive time-matched attention control sessions.
Participants will receive 26 weekly 1-hour small-group sessions and 26 weekly 30-minute individual sessions with a study facilitator. After completing treatment, participants will also receive 6 monthly 1-hour booster sessions. All sessions will focus on promoting healthy behaviors, dieting, and exercise.
Participants will receive 26 weekly 1-hour small-group sessions and 26 weekly 30-minute individual sessions with a study facilitator. After completing treatment, participants will also receive 6 monthly 1-hour booster sessions. All sessions will focus on improving communications, developing healthy techniques for coping with stress, and resolving conflicts.
Jeffrey A. Kelly, PhD
Medical College of Wisconsin
Carol L. Galletly, JD, PhD
Medical College of Wisconsin
Anton M. Somlai, EdD
Medical College of Wisconsin
Jill T. Owczarzak, PhD
Medical College of Wisconsin
333 participants (actual enrollment reported by the registry).
First Submitted
June 30, 2008
First Posted
July 3, 2008
Study Start
July 2006
Date type not reportedThis date has not been verified as actual or estimated.
A Randomized Controlled Trial of Mental Health Peer-Led Education
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Timothy L. McAuliffe, PhD
Medical College of Wisconsin
David W. Seal, PhD
Medical College of Wisconsin
Thomas W. Heinrich, MD
Medical College of Wisconsin
Primary Completion
July 2011
Actual (reported)Study Completion
July 2011
Actual (reported)Last Updated
April 23, 2024
Record last verified: 2024-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: